Gritstone Oncology Inc GRTS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/09/21 EDT
8.98quote price arrow down-0.12 (-1.35%)
Volume
41,815
Close
9.10quote price arrow down-0.13 (-1.41%)
Volume
429,789
52 week range
2.54 - 35.20

...

Loading . . .
  • Open9.08
  • Day High9.22
  • Day Low8.87
  • Prev Close9.23
  • 52 Week High35.20
  • 52 Week High Date01/20/21
  • 52 Week Low2.54
  • 52 Week Low Date11/05/20

Key Stats

  • Market Cap445.45M
  • Shares Out48.95M
  • 10 Day Average Volume2.09M
  • Dividend-
  • Dividend Yield-
  • Beta0.21
  • YTD % Change130.96

KEY STATS

  • Open9.08
  • Day High9.22
  • Day Low8.87
  • Prev Close9.23
  • 52 Week High35.20
  • 52 Week High Date01/20/21
  • 52 Week Low2.54
  • 52 Week Low Date11/05/20
  • Market Cap445.45M
  • Shares Out48.95M
  • 10 Day Average Volume2.09M
  • Dividend-
  • Dividend Yield-
  • Beta0.21
  • YTD % Change130.96

RATIOS/PROFITABILITY

  • EPS (TTM)-2.79
  • P/E (TTM)-3.26
  • Fwd P/E (NTM)-4.00
  • EBITDA (MRQ)-99.298M
  • ROE (MRQ)-69.96%
  • Revenue (MRQ)4.04M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-2,608.07%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/11/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Gritstone Oncology Inc

There is no recent news for this security.

Latest From Our Partners

Profile

MORE
Gritstone Oncology, Inc. is an immuno-oncology company that develops tumor-specific cancer immunotherapies to fight multiple cancer types. The Company focuses to identify and deploy therapeutic neo-antigens from individual patients' tumors to develop treatments for lung cancer. It provides Gritstone EDGE, which is a tumor-specific neo-antigen (TSNA) prediction platform that predicts the presence of a patient’s TSNA on tumor cells. It also develops and manufactures a...
Elaine Jones Ph.D.
Chairman
Andrew Allen M.D., Ph.D.
President
Erin Jones
Chief Operating Officer
James Cho
Chief Accounting Officer
Roman Yelensky Ph.D.
Executive Vice President
Address
5959 HORTON STREET, SUITE 300
Emeryville, CA
94608
United States

Top Peers

SYMBOLLASTCHG%CHG
FIXX
Homology Medicines Inc
7.32-0.16-2.14%
KALV
Kalvista Pharmaceuticals Inc
26.15+0.02+0.08%
OYST
Oyster Point Pharma Inc
20.48-0.52-2.48%
GMDA
Gamida Cell Ltd
7.83-0.25-3.09%
ALDX
Aldeyra Therapeutics Inc
12.04-0.49-3.91%